⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001746614

OH ANDREW M.

Reports to the SEC for 2 companies · CAMBRIDGE, MA

Transactions

10

Companies

2

Filings

6

CIK

0001746614

Forms 4 and 5

Insider transactions

10 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-05	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	16,000
2024-06-05	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-01	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	12,000
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-05-15	Rubius Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$4.74	+$23.7K	5,000
2020-05-15	Rubius Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	755,500
2020-01-31	Rubius Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+165K sh	—	—	165,000
2019-01-31	Rubius Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	115,000

Recent filings

6

Accepted (ET)
Jun 74
OH ANDREW M.0000950170-24-070703
SEC(opens sec.gov)
Jun 24
OH ANDREW M.0001209191-23-033729
SEC(opens sec.gov)
Sep 194
OH ANDREW M.0001209191-22-050556
SEC(opens sec.gov)
May 194
OH ANDREW M.0001179110-20-006356
SEC(opens sec.gov)
Feb 34
OH ANDREW M.0001104659-20-010062
SEC(opens sec.gov)
Feb 44
OH ANDREW M.0001104659-19-005606
SEC(opens sec.gov)

Companies

2

Address

C/O RUBIUS THERAPEUTICS, INC. 325 VASSAR STREET, SUITE 1A

CAMBRIDGE, MA, 02139